Trial Profile
A phase I study investigating safety and various pharmacokinetic attributes of emeramide
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2016
Price :
$35
*
At a glance
- Drugs Emeramide (Primary)
- Indications Heavy metal poisoning
- Focus Adverse reactions; Pharmacokinetics
- 16 Mar 2016 New trial record